This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,570 Years Active: 2013
Title: Innovations of Kangjian Li in Cancer Treatment
Introduction
Kangjian Li is a notable inventor based in Dalian, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the synthesis and application of cyclin-dependent protein kinases (Cdks) inhibitors, which are crucial in the fight against cancer.
Latest Patents
Kangjian Li holds 1 patent related to his invention of a series of flavonoid organic amine derivatives that act as Cdks inhibitors. The patent describes a preparation method that involves using Baicalein or Wogonin as lead compounds, which are mixed with formaldehyde solution and organic amine compounds. This process results in a product with a high purity level, making it a promising candidate for anticancer drugs. The derivatives have shown a remarkable increase in activity, being 50 times more effective than Baicalin in inhibiting Cdks. This innovation has the potential to selectively induce apoptosis in proliferative phase cancer cells while having minimal impact on normal cells.
Career Highlights
Throughout his career, Kangjian Li has demonstrated a commitment to advancing medical science. His research has focused on developing high-efficiency and low-toxicity drugs that can be used in oral preparations or injections. The simplicity of the preparation process and the rich source of raw materials make his inventions particularly valuable in the pharmaceutical industry.
Collaborations
Kangjian Li has worked alongside notable colleagues such as Yongming Bao and Liang Zou. Their collaborative efforts have contributed to the advancement of innovative solutions in cancer treatment.
Conclusion
Kangjian Li's contributions to the field of cancer treatment through his innovative patents highlight the importance of research and development in pharmaceuticals. His work not only showcases the potential for new anticancer drugs but also emphasizes the need for continued innovation in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile